Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tursz

Showing results (71-80 of 231) with videos related to

Pageof 24
Sort By:
British Medical Journal|June 22, 1974
Simultaneous occurrence of acute myeloblastic leukaemia and multiple myeloma without previous chemotherapyT Tursz, G Flandrin, J C Brouet, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Comparison of HLA phenotypes in long-term survivors with acute lymphoblastic leukemia treated with immunotherapy versus chemotherapyT Tursz, J Hors, M Lipinski, et al.
The Journal of Biological Chemistry|December 10, 1984
Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell linesJ Wiels, E H Holmes, N Cochran, et al.
The Journal of Experimental Medicine|November 1, 1983
HNK-1 antibody detects an antigen expressed on neuroectodermal cellsM Lipinski, K Braham, J M Caillaud, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 23, 1977
[Cytotoxicity of human T-lymphocytes sensitized by Epstein-Barr virus. Role of HLA antigens at the surface of target cells infected by the virus]T Tursz, W H Fridman, A Tsapis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1983
Leukemia cell lines can replace monocytes for mitogen-induced T-lymphocyte responses: this accessory function is dependent upon their differentiation stageH Wakasugi, A Harel, M C Dokhelar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Accessory function and interleukin 1 production by human leukemic cell linesH Wakasugi, A Harel, M C Dokhelar, et al.
Transplantation|March 1, 1980
Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapyM Lipinski, T Tursz, H Kreis, et al.
The Journal of Clinical Investigation|August 1, 1977
Autoantibodies to B lymphocytes in a patient with hypoimmunoglobulinemia. Characterization and pathogenic roleT Tursz, J L Preud'homme, S Labaume, et al.
Experimental Hematology|October 1, 1985
HLA class-I and class-II antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferonD Garson, M C Dokhélar, H Wakasugi, et al.
Pageof 24

Showing results (71-80 of 231) with videos related to

Sort By:
Pageof 24
British Medical Journal|June 22, 1974
Simultaneous occurrence of acute myeloblastic leukaemia and multiple myeloma without previous chemotherapyT Tursz, G Flandrin, J C Brouet, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Comparison of HLA phenotypes in long-term survivors with acute lymphoblastic leukemia treated with immunotherapy versus chemotherapyT Tursz, J Hors, M Lipinski, et al.
The Journal of Biological Chemistry|December 10, 1984
Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell linesJ Wiels, E H Holmes, N Cochran, et al.
The Journal of Experimental Medicine|November 1, 1983
HNK-1 antibody detects an antigen expressed on neuroectodermal cellsM Lipinski, K Braham, J M Caillaud, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 23, 1977
[Cytotoxicity of human T-lymphocytes sensitized by Epstein-Barr virus. Role of HLA antigens at the surface of target cells infected by the virus]T Tursz, W H Fridman, A Tsapis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1983
Leukemia cell lines can replace monocytes for mitogen-induced T-lymphocyte responses: this accessory function is dependent upon their differentiation stageH Wakasugi, A Harel, M C Dokhelar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Accessory function and interleukin 1 production by human leukemic cell linesH Wakasugi, A Harel, M C Dokhelar, et al.
Transplantation|March 1, 1980
Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapyM Lipinski, T Tursz, H Kreis, et al.
The Journal of Clinical Investigation|August 1, 1977
Autoantibodies to B lymphocytes in a patient with hypoimmunoglobulinemia. Characterization and pathogenic roleT Tursz, J L Preud'homme, S Labaume, et al.
Experimental Hematology|October 1, 1985
HLA class-I and class-II antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferonD Garson, M C Dokhélar, H Wakasugi, et al.
Pageof 24